Artwork
iconShare
 
Manage episode 523672679 series 3642142
Content provided by TRT DAD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TRT DAD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a text

Today, the FDA met with a panel of experts to discuss testosterone replacement therapy, its risks, benefits and the future of access for millions of men. So we brought in the heavy hitters.

In this roundtable breakdown, Mike Belkin (Mens HealthSpan), Mason Collins (Live Oak Testosterone), Rick Collins (Defense Lawyer) and Josh Dull (Virtus Health Optimization) sit down with TRT DAD to cut through the noise and tell you what the FDA meeting really means for TRT clinics, patients and the entire men's health industry.

This is the episode everyone in the TRT community needs to hear.

No fear mongering. No spin. Just real talk, real experts and real answers.

TRTDAD.com

Virtushealthoptimization.com

@TRTDAD on YouTube

@trt_dad on Instagram

Virtushealthoptimization.com

  continue reading

58 episodes